7.8K(top 0.1%)
papers
161.2K(top 0.1%)
citations
129(top 0.1%)
h-index
225(top 0.1%)
g-index
8.3K
all documents
175.8K
doc citations
9.4K
citing journals
9.8K
times ranked

Top Articles

#TitleJournalYearCitations
1Guidelines for the use and interpretation of assays for monitoring autophagyAutophagy20123,122
2A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statementJournal of Hepatology20202,171
3Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 updateHepatology International20161,908
4Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 updateHepatology International20171,537
5Large-scale association analysis identifies new risk loci for coronary artery diseaseNature Genetics20131,439
6Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1Autophagy20211,430
7Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinomaHepatology International2010944
8Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 updateHepatology International2012874
9Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis BHepatology2010840
10Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 updateHepatology International2008832
11New trends on obesity and NAFLD in AsiaJournal of Hepatology2017759
12Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosisJournal of Hepatology2017734
13Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19Science Immunology2020689
14Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genesNature Genetics2012560
15Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysisGut2013497
16A systematic review of hepatitis C virus epidemiology in Asia, Australia and EgyptLiver International2011481
17Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort studyBMJ: British Medical Journal2004477
18Mechanisms of acquired resistance to first- and second-generation EGFR tyrosine kinase inhibitorsAnnals of Oncology2018449
19Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non–Small-Cell Lung CancerJournal of Clinical Oncology2022445
20Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogueNature2000424
21The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver diseaseHepatology International2020422
22Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea Symposium on Autoimmune PancreatitisJournal of Gastroenterology2008418
23Metabolic Significance of Nonalcoholic Fatty Liver Disease in Nonobese, Nondiabetic AdultsArchives of Internal Medicine2004373
24Asia–Pacific Working Party on Non‐alcoholic Fatty Liver Disease guidelines 2017—Part 1: Definition, risk factors and assessmentJournal of Gastroenterology and Hepatology (Australia)2018358
25Oncogenic Pathway Combinations Predict Clinical Prognosis in Gastric CancerPLoS Genetics2009354
26Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trialLancet Oncology, The2014336
27Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan)Hepatology2011329
28Entecavir Therapy for up to 96 Weeks in Patients With HBeAg-Positive Chronic Hepatitis BGastroenterology2007324
29Four-Year Survival With Durvalumab After Chemoradiotherapy in Stage III NSCLC—an Update From the PACIFIC TrialJournal of Thoracic Oncology2021323
30Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology CommissionThe Lancet Gastroenterology and Hepatology2020320
31Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormoneInternational Journal of Obesity1997318
32Gut commensal Bacteroides acidifaciens prevents obesity and improves insulin sensitivity in miceMucosal Immunology2017310
33Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in KoreaJournal of Korean Medical Science2020283
34Serous cystic neoplasm of the pancreas: a multinational study of 2622 patients under the auspices of the International Association of Pancreatology and European Pancreatic Club (European Study Group on Cystic Tumors of the Pancreas)Gut2016274
35Data Analytic Process of a Nationwide Population-Based Study Using National Health Information Database Established by National Health Insurance ServiceDiabetes and Metabolism Journal2016269
36Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract CancerDiabetes and Metabolism Journal2022267
37CD44‐positive cells are responsible for gemcitabine resistance in pancreatic cancer cellsInternational Journal of Cancer2009266
38The Prognosis and Survival Outcome of Intrahepatic Cholangiocarcinoma Following Surgical Resection: Association of Lymph Node Metastasis and Lymph Node Dissection with SurvivalAnnals of Surgical Oncology2009265
39Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: Nationwide surveys (KNHANES 2008–2011)Journal of Hepatology2015264
40SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular diseaseNature Communications2020263
41Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008‐2011)Hepatology2016261
42Metformin alleviates hepatosteatosis by restoring SIRT1-mediated autophagy induction via an AMP-activated protein kinase-independent pathwayAutophagy2015252
43Preventative Effects of Rosiglitazone on Restenosis After Coronary Stent Implantation in Patients With Type 2 DiabetesDiabetes Care2004245
44Performance of Transient Elastography for the Staging of Liver Fibrosis in Patients with Chronic Hepatitis B: A Meta-AnalysisPLoS ONE2012242
45Liver cancer: Approaching a personalized careJournal of Hepatology2015239
46Prognostic value of sarcopenia in patients with liver cirrhosis: A systematic review and meta-analysisPLoS ONE2017237
47Clinical characteristics and outcomes of Takayasu's arteritis: analysis of 108 patients using standardized criteria for diagnosis, activity assessment, and angiographic classificationScandinavian Journal of Rheumatology2005234
48Mechanisms of acquired resistance to first-line osimertinib: Preliminary data from the phase III FLAURA studyAnnals of Oncology2018229
49Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patientsLiver International2010225
50Acquired resistance to EGFR targeted therapy in non-small cell lung cancer: Mechanisms and therapeutic strategiesCancer Treatment Reviews2018225